U.S. Stocks Rally as Fear Index Eases Slightly
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 10 2026
0mins
Should l Buy ORCL?
Source: Benzinga
- Fear Index Update: The CNN Money Fear & Greed Index recorded a reading of 27.3 on Monday, up from 25.2 previously, indicating a slight easing in fear but still reflecting cautious market sentiment.
- Market Recovery: On Monday, U.S. stocks rallied, with the Nasdaq Composite gaining over 300 points during the session, closing at 22,695.95, showcasing a strong rebound in tech stocks despite last week's overall declines.
- Major Index Movements: The Dow Jones rose by approximately 239 points to close at 47,740.80, while the S&P 500 increased by 0.83% to 6,795.99, reflecting optimistic market sentiment, particularly in communication, healthcare, and information technology sectors.
- Sector Performance Divergence: While most sectors closed higher, energy and financial stocks fell, indicating internal market divergences that could affect investor confidence and future market trends.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ORCL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ORCL
Wall Street analysts forecast ORCL stock price to rise
34 Analyst Rating
25 Buy
9 Hold
0 Sell
Moderate Buy
Current: 181.170
Low
180.00
Averages
309.59
High
400.00
Current: 181.170
Low
180.00
Averages
309.59
High
400.00
About ORCL
Oracle Corporation offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. The Company operates through three businesses: cloud and license, hardware and service. Its cloud and license business is engaged in the sale, marketing and delivery of its enterprise applications and infrastructure technologies through cloud and on-premise deployment models including its cloud services and license support offerings, and its cloud license and on-premise license offerings. Its hardware business provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management and other hardware-related software to support diverse IT environments. Its services business provides services to customers and partners to help maximize the performance of their investments in Oracle applications and infrastructure technologies.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Digital Identity Verification: Oracle Health simplifies patient check-in by integrating the CLEAR1 platform, allowing patients to quickly verify their identity through a QR code, thereby eliminating redundant information gathering and enhancing service efficiency and patient experience.
- Support for CMS Initiative: As part of the CMS Aligned Network, Oracle Health is committed to simplifying healthcare data sharing, reducing fragmentation in services, and improving the coherence of clinical workflows, thus enhancing how patients and clinicians access necessary information.
- Successful Case Study: New Jersey-based AtlantiCare has fully integrated this technology, achieving a paperless check-in process where verified patient information flows securely into their system, significantly reducing wait times and repetitive medical history collection, thereby enhancing the connection experience for patients and providers.
- Driving Industry Transformation: Oracle Health's technology supports the CMS Aligned Network, aiming to accelerate healthcare data sharing and ensure patients can conveniently access and control their health data, pushing the healthcare industry towards a more interconnected and patient-centered approach.
See More
- Partnership Expansion: Oracle has announced an expansion of its partnership with Google Cloud, launching the Oracle AI Database Agent to provide enterprise customers with a simpler way to manage data using natural language, thereby enhancing customer experience and accelerating cloud migrations.
- New Features Launched: Oracle AI Database@Google Cloud will offer new capabilities and broader regional availability, with global organizations like Worldline leveraging these features to drive innovation and enhance market competitiveness.
- AI Application Enhancement: By applying AI directly at the database layer, customers can improve data processing accuracy and controls while using models more efficiently without exposing sensitive data, thus reducing complexity.
- Positive Market Reaction: Oracle's shares jumped 3% in premarket trading to $186.83, reflecting investor optimism regarding the company's new partnership and its potential for business growth.
See More

Oracle Expands AI Capabilities: Oracle has enhanced its AI capabilities within Oracle AI Data Base, aiming to provide more powerful tools for enterprise data management.
Integration with Google Cloud: The new features are designed to supercharge enterprise data innovation by leveraging Google Cloud's infrastructure and services.
See More
- Ceasefire Extension: President Trump has extended the Iran ceasefire deadline by two weeks, a move that may exacerbate uncertainty in the Middle East conflict as Tehran shows reluctance to engage in diplomatic efforts, potentially impacting global market sentiment.
- Tariff Policy Impact: Trump expressed hope that U.S. companies that have not sought refunds for his tariffs will adhere to a 'no take back' policy, despite the Supreme Court ruling the tariffs illegal; major firms like Apple and Amazon have yet to file for refunds, which could affect their future financial performance.
- Market Reaction: Following Trump's announcement of the ceasefire extension, U.S. stock index futures rose, despite a lower close on Tuesday, while crude oil prices increased, indicating market sensitivity to developments in the Middle East.
- Aviation Industry Outlook: United Airlines has slashed its 2026 earnings outlook due to supply chain issues stemming from the Middle East conflict, reflecting the direct impact of soaring fuel prices on the airline industry and potentially leading to broader industry adjustments.
See More
- Poor Performance of Magnificent Seven: In the first quarter, every stock in the Magnificent Seven experienced negative growth, with declines ranging from 6% to 23%, reflecting a significant drop in investor confidence in growth stocks amid uncertainties like the Iran conflict.
- Challenging Market Environment: The war in Iran has driven up oil prices and complicated industrial supply deliveries, exacerbating investor concerns about tech stocks, particularly regarding the future returns of AI investments.
- Historical Performance Review: Despite facing challenges, the Magnificent Seven has achieved triple or quadruple-digit growth over the past 20 years, with historical data indicating that quality tech stocks tend to rebound quickly, providing hope for shareholders.
- Diversification Investment Strategy: While the Magnificent Seven remains a key growth driver, other strong tech companies like Broadcom and Oracle are also showing impressive growth, suggesting that investors should consider diversifying their portfolios to capture broader market opportunities amid the AI boom.
See More
- Market Performance: The S&P 500 Index fell by 0.13%, and the Dow Jones Industrial Average also declined by 0.13%, while the Nasdaq 100 saw a slight increase of 0.02%, reflecting market volatility influenced by oil price rebounds and economic data.
- Strong Economic Data: March retail sales rose by 1.7% month-over-month, exceeding expectations of 1.4%, marking the largest increase in a year, indicating robust consumer spending that may support stock prices.
- Oil Price Recovery: WTI crude oil prices rebounded by over 2% as market speculation intensified regarding Iran's participation in upcoming peace talks, potentially exacerbating the global energy crisis.
- Impressive Earnings Reports: UnitedHealth Group reported Q1 adjusted EPS of $9.23, significantly above the consensus of $6.57, leading to a stock price increase of over 7% and raising its full-year earnings forecast, showcasing strong performance in the health insurance sector.
See More










